ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Optimal Blue 30Yr Conf Fxd 680-699 FICO 0-80 LTV

Optimal Blue 30Yr Conf Fxd 680-699 FICO 0-80 LTV (OB30680L)

0.00
0.00
( 0.00% )

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
-
Price Change
-
Change %
-
Name
Optimal Blue 30Yr Conf Fxd 680-699 FICO 0-80 LTV
Symbol
OB30680L
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Bid
-
Ask
-
Open
-
High
0.00
Low
0.00
Close
-
Previous Close
-
Market
NASDAQ Indices
Type
Index

OB30680L Latest News

Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024

ST. LOUIS, July 22, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it...

Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir

ST. LOUIS, July 18, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced the appointment of Nachum...

Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment

ST. LOUIS, May 29, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announces the successful treatment of...

Stereotaxis Receives CE Mark Recertification Under EU’s MDR Regulatory Framework

ST. LOUIS, May 24, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it...

First Heart Rhythm Patients in Southern Italy Treated with Advanced Robotic Technology

ST. LOUIS, May 22, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced that Hospital Santa Maria...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000IX
40000000IX
120000000IX
260000000IX
520000000IX
1560000000IX
2600000000IX
Indices
Commodities
Forex
US5005,440.83-6.78-0.12%
US3040,700.00149.000.37%
US1002,617.81-6.49-0.25%
DJI40,707.15167.220.41%
SP5005,458.06-5.48-0.10%
COMPX17,297.43-72.77-0.42%
DXY104.3010.1410.14%

Your Recent History

Delayed Upgrade Clock